Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
adverse drug reaction
alkylating agents
amphiphysin antibodies
antihistamines
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
autonomic neuropathy
azathioprine
B cell lymphocytes
Barkhof MR criteria for MS
bone marrow suppression
carcinoma
carcinoma of breast
carcinoma of lung
central nervous system, infection of
cerebellar atrophy, secondary
cerebellar degeneration
cerebral cortex
cerebral cortical atrophy
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, secondary prevention
cladribine
clemastine fumarate
clinicoradiologic dissociation
collapsin response mediator protein 5 IgG
complications
contactin associated protein like 2 antibodies
controversies in neurology
cop 1
cost effectiveness
cyclophosphamide
cyclosporine
dermatomyositis
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalitis, viral
encephalomyelitis
epidemiology of neurology
evoked potentials
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
ganglionitis
gray matter
herpes virus infection
highly active antiretroviral therapy
human immunodeficiency virus type 1
hypertension
immune reconstitution inflammatory syndrome
immunocompetent
immunologic disease
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
impotence
infection
interferon
interferon beta 1-a
interferon beta 1-b
JC virus
leucine rich glioma inactivated 1 antibodies
limbic encephalitis
malignancy screen
malignancy, occult
methotrexate
middle cerebellar peduncle
middle cerebellar peduncle, lesion
misdiagnosis
mitoxantrone
monoclonal antibodies
mononeuritis multiplex
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, delayed
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, false negative
MRI, serial
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, benign form of
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelopathy
myelopathy, necrotizing
natalizumab
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic examination
neurologic practice
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuropathology
neuropathy
neuropathy, paraneoplastic
neuropathy, peripheral
NMDA antagonists
ocrelizumab
onconeural antibodies
opsoclonus-myoclonus syndrome
paraneoplastic cerebellar degeneration
paraparesis
paraparesis, spastic
peripheral nerve, lesion of
placebo
plasmapheresis
pleocytosis of cerebrospinal fluid
practice guidelines
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychological testing
quality of life
ReBUILD study
Red flags
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
remyelination
renal failure
retinopathy
review article
safety
screening
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
steroid
steroid therapy, CNS treatment and complications with
thrombocytopenia
treatment of neurologic disorder
tumor necrosis factor
viral infection
viral infection, CNS
viral infection, reactivation
visual evoked response
visual loss
wheelchair
white matter disease
white matter, dirty-appearing
workup
xerophthalmia
xerostomia
Showing articles 500 to 550 of 6235 << Previous Next >>

Mycophenolate Mofetil in Multiple Sclerosis: A Multicentre Retrospective Study on 344 Patients
JNNP 85:279-283,246, Michel, L.,et al, 2014

Addition of Hyperacute MRI Aids in Patient Selection, Decreasing the Use of Endovascular Stroke Therapy
Stroke 45:467-472, Wisco, D.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis
NEJM 370:792-794, McMinn, P.C., 2014

Relapsing-Remitting Tumefactive Demyelination
JAMA Neurol 71:366-367, Brandao, E.,et al, 2014

Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014

Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:1083-1092, Yadav, V.,et al, 2014

Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:e103-e104, Fox, R.J., 2014

Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial
Lancet 383:2213-2221, Chataway, J.,et al, 2014

Snowball-like Lesions with Sudden Hearing Loss
Neurol 82:e100, Oliveira, P. & Mayeux, J., 2014

Cerebral Venous Thrombosis after High Dose Steroid in Multiple Sclerosis: A Case Report
Hippokratia 17:88-90, Gazioglu, S.,et al, 2013

Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Ann Neurol 74:679-687, Krueger, D.A.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

Clinical Features of MS Associated with Leber Hereditary Optic Neuropathy mtDNA Mutations
Neurol 81:2073-2081, Pfeffer, G.,et al, 2013

Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013

Macroglossia in Amyotrophic Lateral Sclerosis
JAMA Neurol 70:1432-1435, McKee, H.R.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Ann Neurol 73:705-713, Khan, O.,et al, 2013

Interdependence and Contributions of Sun Exposure and Vitamin D to MRI Measures in Multiple Sclerosis
JNNP 84:1075-1081, 1066, Zivadinov, R.,et al, 2013

Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013

Incidence and Pathology of Synucleinopathies and Tauopathies Related to Parkinsonism
JAMA Neurol 70:859-866, Savica, R.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Extensive Vasogenic Edema of Anti-Aquaporin-4 Antibody-Related Brain Lesions
Mult Scler 15:1113-1117, Matsushita, T.,et al, 2013

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Facial Bradykinesia
JNNP 84:681-685, Bologna, M.,et al, 2013

Disability in Multiple Sclerosis
Neurol 80:1018-1024, Kister, I.,et al, 2013

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013

The Thalamus and Multiple Sclerosis
Neurol 80:210-219, Minagar, A.,et al, 2013

Location of Brain Lesions Predicts Conversion of Clinically Isolated Syndromes to Multiple Sclerosis
Neurol 80:234-241, Giorgio, A.,et al, 2013

Spinal Cord Lesions in Patients with Clinically Isolated Syndrome
Neurol 80:69-75, Sombekke, M.,et al, 2013

Aspergillus Meningitis: A Rare Clinical Manifestation of Central Nervous System Aspergillosis
J Infect 66:218-238, Antinori, S.,et al, 2013

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Central Nervous System Lymphoma Initial Diagnosed as Tumefective Multiple Sclerosis after Brian Biopsy
Intern Med 52:483-488, Ohe, Y.,et al, 2013

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012

Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012

The Differential Diagnosis of Longitudinally Extensive Transverse Myelitis
Mult Scler 18:271-285, Kitley, J.L.,et al, 2012

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis International ID 735486, Kim, W.,et al, 2012

Cerebral Sinus Thrombosis in Scleroderma
Acta Med Iran 50:288-291, Fard, M.P. & Magham, S.K., 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Should we be nervous about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurologic opinion
JNNP 83:1216-1221, Currie, S.,et al, 2012



Showing articles 500 to 550 of 6235 << Previous Next >>